REFLESA Trademark

Trademark Overview

On Friday, February 11, 2011, a trademark application was filed for REFLESA with the United States Patent and Trademark Office. The USPTO has given the REFLESA trademark a serial number of 85240303. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 25, 2014. This trademark is owned by XenoPort, Inc.. The REFLESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of central nervous system disorders, gastrointestinal disorders, hematological disorders, autoimmune disorders, genetic disorders, inflammatory disorders, dermatological disorders and for the treatment of pain
reflesa

General Information

Serial Number85240303
Word MarkREFLESA
Filing DateFriday, February 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 25, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of central nervous system disorders, gastrointestinal disorders, hematological disorders, autoimmune disorders, genetic disorders, inflammatory disorders, dermatological disorders and for the treatment of pain
Translation of Words in MarkThe word "REFLESA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXenoPort, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95051
Party NameXenoPort, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95051

Trademark Events

Event DateEvent Description
Monday, August 25, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 25, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, February 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2014EXTENSION 4 GRANTED
Tuesday, January 21, 2014EXTENSION 4 FILED
Tuesday, January 21, 2014TEAS EXTENSION RECEIVED
Wednesday, July 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2013EXTENSION 3 GRANTED
Friday, July 12, 2013EXTENSION 3 FILED
Friday, July 12, 2013TEAS EXTENSION RECEIVED
Thursday, January 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 30, 2013EXTENSION 2 GRANTED
Monday, January 7, 2013EXTENSION 2 FILED
Wednesday, January 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 7, 2013TEAS EXTENSION RECEIVED
Wednesday, July 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 9, 2012EXTENSION 1 GRANTED
Monday, July 9, 2012EXTENSION 1 FILED
Monday, July 9, 2012TEAS EXTENSION RECEIVED
Monday, July 9, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 27, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 20, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 17, 2011ASSIGNED TO LIE
Thursday, October 6, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 14, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 14, 2011NON-FINAL ACTION E-MAILED
Thursday, April 14, 2011NON-FINAL ACTION WRITTEN
Monday, April 11, 2011ASSIGNED TO EXAMINER
Wednesday, February 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 15, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

reflesa disorders treatment genetic autoimmune inflammatory dermatological pain hematological pharmaceutical central